Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue (Q44610001)

4 December 2017

Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue (English)

1 reference

4 December 2017

0 references

1 reference

Bente Klarlund Pedersen

series ordinal

5

1 reference

4 December 2017

4

Charlotte Keller

1 reference

4 December 2017

2

Peter Plomgaard

1 reference

4 December 2017

3

Pernille Keller

1 reference

4 December 2017

1

Rikke Krogh-Madsen

1 reference

PubMed ID

14532168

4 December 2017

language of work or name

1 reference

7 October 2003

1 reference

American Journal of Physiology - Endocrinology and Metabolism

4 December 2017

1 reference

4 December 2017

286

1 reference

4 December 2017

2

1 reference

4 December 2017

E234-8

1 reference

Intensive insulin therapy in critically ill patients

4 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Interleukin-6 gene expression is increased in insulin-resistant rat skeletal muscle following insulin stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Interleukin (IL)-6 mRNA Expression is Stimulated by Insulin, Isoproterenol, Tumour Necrosis Factor Alpha, Growth Hormone, and IL-6 in 3T3-L1 Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Interleukin-6 stimulates lipolysis and fat oxidation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Muscle-derived interleukin-6: possible biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

The expression of TNF alpha by human muscle. Relationship to insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Carbohydrate ingestion attenuates the increase in plasma interleukin-6, but not skeletal muscle interleukin-6 mRNA, during exercise in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Characterization of vectorial chloride transport pathways in the human pancreatic duct adenocarcinoma cell line HPAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Interleukin-6-deficient mice develop mature-onset obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Hormonal regulation of interleukin-6 production in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Exercise induces hepatosplanchnic release of heat shock protein 72 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00274.2003

10.1152/AJPENDO.00274.2003

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference

PubMed ID

14532168